Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > David Happel > Profile

David Happel

Affiliations

President & Ceo at Sagimet Biosciences Inc. (SGMT), 2024-03-28
Evp, Commercial Dev & Strategy at Horizon Pharma Plc (HZNP), 2017-10-26
Chief Commercial Officer at Raptor Pharmaceutical Corp (RPTP), 2016-10-26

Insider Trading: Purchases See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Sagimet Biosciences Inc.	SGMT	$5.27	12,100	Officer, Director	639,200	2024-03-26	Filing
Sagimet Biosciences Inc.	SGMT	$4.10	1,600	Officer, Director	627,100	2023-12-07	Filing
Sagimet Biosciences Inc.	SGMT	$2.35	590	Officer, Director	590	2023-11-16	Filing